9999999997-16-022530.txt : 20160427 9999999997-16-022530.hdr.sgml : 20160427 20160427130027 ACCESSION NUMBER: 9999999997-16-022530 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160427 DATE AS OF CHANGE: 20160427 20160427 20160427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADURO BIOTECH, INC. CENTRAL INDEX KEY: 0001435049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-37345 FILM NUMBER: 161594370 BUSINESS ADDRESS: STREET 1: 626 BANCROFT WAY STREET 2: SUITE 3-C CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 510-848-4400 MAIL ADDRESS: STREET 1: 626 BANCROFT WAY STREET 2: SUITE 3-C CITY: BERKELEY STATE: CA ZIP: 94710 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH DATE OF NAME CHANGE: 20080514 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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